866-997-4948(US-Canada Toll Free)

Global Market Study on Botulinum Toxin: Growing Number of FDA Approvals for New Indications to Place Market Revenue on a Steady Growth Path

Published By :

Persistence Market Research

Published Date : May 2018

Category :

Pharmaceutical

No. of Pages : 214 Pages

This Persistence Market Research (PMR) report examines the global botulinum toxin market for the period 20182026. The primary objective of the report is to offer insights into market opportunities for botulinum toxin and key developments in the botulinum toxin market. The market for botulinum toxin is primarily driven by expanding applications, approvals of new therapies and approvals in emerging markets. However, counterfeit products remain to be the biggest challenge in the market.

Market Segmentation

  • Product Types
  • Type A
  • Type B
  • Applications
  • Cosmetic Applications
  • Crows Feet
  • Forehead Lines
  • Frown Lines/Galbellar
  • Square Jaw Masseter
  • Others
  • Therapeutic Applications
  • Chronic Migraine
  • Muscle Spasm
  • Over Reactive Bladder
  • Hyperhydrosis
  • Others

End Users

  • Hospitals
  • Specialty Clinics
  • Spas & Beauty Clinics

Regions

  • North America
  • Latin America
  • Europe
  • China
  • Asia Pacific excluding China
  • Middle East and Africa (MEA)

The report analyses the global botulinum toxin market in terms of value (US$ Mn). The report begins with the market definition and an explanation of the different product types, applications and end users. The market view point section includes an analysis of key trends, drivers, opportunities, trends and macro factors influencing the global market. The report also presents an analysis of the different regional markets by product, application, end user and country. Representative market participants section gives a list of companies operating in every region, the prevalent competitive landscape and intensity map of key players presence in each region.

Research Methodology

To arrive at the market size, we have used our in-house procedure volume model, market share and market structure model to estimate botulinum toxin market size. We have adopted the bottom-up approach to forecast the market size of botulinum toxin globally. The following parameters have been used to estimate the market size for the base year 2017:

  • Country level data for botulinum toxin cosmetic procedures
  • Average number of units of botulinum toxin required per procedure
  • Average cost of botulinum toxin

Weighted average selling price is considered to estimate the market size of botulinum toxin mentioned in the scope of the study. The country price is captured with the local currency and then converted to USD to offer forecasts in a consistent currency standard. Furthermore, we have considered the latest annual exchange rate to reflect the impact of the most recent economic conditions of each assessed country. Prices considered in the models are standardized based on the average dosage recommended per procedure.

The forecast presented in the report provides total revenue of currently approved botulinum toxin products over 20182026. In addition, we have taken into consideration the year-on-year growth to understand the predictability of the market and to identify the right growth opportunities in the global market.

An important section of the report focuses on the competitive landscape to provide report audiences with a dashboard view and to access the key differentiators among the competitor firms. Market structure analysis provides tier wise breakdown of total market revenue. The section also provides company share analysis for key market players. This section is primarily designed to provide clients with an objective and detailed comparative assessment of product offerings and strategies of key providers specific to the different market segments. Detailed profiles of players in the botulinum toxin market are also provided in the report with company overview, product/segment overview, SWOT analysis, financial information, key developments related to the market and a strategic overview.

Another key feature of this report is the analysis of the key market segments in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective of the products. To understand key growth segments, Persistence market Research provides the Attractiveness Index analysis to help clients identify real market opportunities.

Table of Content

1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. PMR Analysis and Recommendations
1.4. Wheel of Fortune

2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy

3. Botulinum Toxin Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis

4. Market Background
4.1. List of Growth Hacking Manufacturers
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Porters Analysis
4.3. Regulatory Scenario

5. Macroeconomic Assumptions

6. North America Botulinum Toxin Market Analysis 20132017 and Forecast 20182026

6.1. Introduction
6.2. Regional Market Trends
6.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 20132017
6.3.1. U.S.
6.3.2. Canada
6.4. Market Size (US$ Mn) Forecast By Country, 20182026
6.5. Historical Market Size (US$ Mn) Trend Analysis By Type of Toxin, 20132017
6.5.1. Type A
6.5.2. Type B
6.6. Market Size (US$ Mn) Forecast By Type of Toxin, 20182026
6.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 20132017
6.7.1. Cosmetic Application
6.7.1.1. Frown Lines/Galbellar
6.7.1.2. Crows Feet
6.7.1.3. Forehead Lines
6.7.1.4. Square Jaw Masseter
6.7.1.5. Others
6.7.2. Therapeutic Application
6.7.2.1. Chronic Migraine
6.7.2.2. Muscle Spasms
6.7.2.3. Over Reactive Bladder
6.7.2.4. Hyperhidrosis
6.7.2.5. Others
6.8. Market Size (US$ Mn) Forecast By Application, 20182026
6.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 20132017
6.9.1. Hospitals
6.9.2. Specialty Clinics
6.9.3. Spas & Beauty Clinics
6.10. Market Size (US$ Mn) Forecast By End User, 20182026
6.11. Drivers and Restraints: Impact Analysis
6.12. Market Attractiveness Analysis
6.12.1. By Country
6.12.2. By Type of Toxin
6.12.3. By Application
6.12.4. By End User
6.13. Key Market Participants Intensity Mapping
6.14. Drivers and Restraints Impact Analysis
6.15. Key Mergers & Acquisitions

7. Latin America Botulinum Toxin Market Analysis 20132017 and Forecast 20182026
7.1. Introduction
7.2. Regional Market Trends
7.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 20132017
7.3.1. Argentina
7.3.2. Brazil
7.3.3. Mexico
7.3.4. Rest of Latin America
7.4. Market Size (US$ Mn) Forecast By Country, 20182026
7.5. Historical Market Size (US$ Mn) Trend Analysis By Type of Toxin, 20132017
7.5.1. Type A
7.5.2. Type B
7.6. Market Size (US$ Mn) Forecast By Type of Toxin, 20182026
7.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 20132017
7.7.1. Cosmetic Application
7.7.1.1. Frown Lines/Galbellar
7.7.1.2. Crows Feet
7.7.1.3. Forehead Lines
7.7.1.4. Square Jaw Masseter
7.7.1.5. Others
7.7.2. Therapeutic Application
7.7.2.1. Chronic Migraine
7.7.2.2. Muscle Spasms
7.7.2.3. Over Reactive Bladder
7.7.2.4. Hyperhidrosis
7.7.2.5. Others
7.8. Market Size (US$ Mn) Forecast By Application, 20182026
7.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 20132017
7.9.1. Hospitals
7.9.2. Specialty Clinics
7.9.3. Spas & Beauty Clinics
7.10. Market Size (US$ Mn) Forecast By End User, 20182026
7.11. Drivers and Restraints: Impact Analysis
7.12. Market Attractiveness Analysis
7.12.1. By Country
7.12.2. By Type of Toxin
7.12.3. By Application
7.12.4. By End User
7.13. Key Market Participants Intensity Mapping
7.14. Drivers and Restraints Impact Analysis
7.15. Key Mergers & Acquisitions

8. Europe Botulinum Toxin Market Analysis 20132017 and Forecast 20182026
8.1. Introduction
8.2. Regional Market Trends
8.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 20132017
8.3.1. Germany
8.3.2. U.K.
8.3.3. France
8.3.4. Italy
8.3.5. Spain
8.3.6. Russia
8.3.7. Rest of Europe
8.4. Market Size (US$ Mn) Forecast By Country, 20182026
8.5. Historical Market Size (US$ Mn) Trend Analysis By Type of Toxin, 20132017
8.5.1. Type A
8.5.2. Type B
8.6. Market Size (US$ Mn) Forecast By Product Type, 20182026
8.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 20132017
8.7.1. Cosmetic Application
8.7.1.1. Frown Lines/Galbellar
8.7.1.2. Crows Feet
8.7.1.3. Forehead Lines
8.7.1.4. Square Jaw Masseter
8.7.1.5. Others
8.7.2. Therapeutic Application
8.7.2.1. Chronic Migraine
8.7.2.2. Muscle Spasms
8.7.2.3. Over Reactive Bladder
8.7.2.4. Hyperhidrosis
8.7.2.5. Others
8.8. Market Size (US$ Mn) Forecast By Application, 20182026
8.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 20132017
8.9.1. Hospitals
8.9.2. Specialty Clinics
8.9.3. Spas & Beauty Clinics
8.10. Market Size (US$ Mn) Forecast By End User, 20182026
8.11. Drivers and Restraints: Impact Analysis
8.12. Market Attractiveness Analysis
8.12.1. By Country
8.12.2. By Type of Toxin
8.12.3. By Application
8.12.4. By End User
8.13. Key Market Participants Intensity Mapping
8.14. Drivers and Restraints Impact Analysis
8.15. Key Mergers & Acquisitions

9. Asia Pacific Botulinum Toxin Market Analysis 20132017 and Forecast 20182026
Market forecast and analysis in Japan, India, Australia and New Zealand, and
Rest of Asia Pacific
9.1. Introduction
9.2. Regional Market Trends
9.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 20132017
9.3.1. Japan
9.3.2. India
9.3.3. Australia and New Zealand
9.3.4. Rest of Asia Pacific
9.4. Market Size (US$ Mn) Forecast By Country, 20182026
9.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 20132017
9.5.1. Type A
9.5.2. Type B
9.6. Market Size (US$ Mn) Forecast By Product Type, 20182026
9.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 20132017
9.7.1. Cosmetic Application
9.7.1.1. Frown Lines/Galbellar
9.7.1.2. Crows Feet
9.7.1.3. Forehead Lines
9.7.1.4. Square Jaw Masseter
9.7.1.5. Others
9.7.2. Therapeutic Application
9.7.2.1. Chronic Migraine
9.7.2.2. Muscle Spasms
9.7.2.3. Over Reactive Bladder
9.7.2.4. Hyperhidrosis
9.7.2.5. Others
9.8. Market Size (US$ Mn) Forecast By Application, 20182026
9.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 20132017
9.9.1. Hospitals
9.9.2. Specialty Clinics
9.9.3. Spas & Beauty Clinics
9.10. Market Size (US$ Mn) Forecast By End User, 20182026
9.11. Drivers and Restraints: Impact Analysis
9.12. Market Attractiveness Analysis
9.12.1. By Country
9.12.2. By Type of Toxin
9.12.3. By Application
9.12.4. By End User
9.13. Key Market Participants Intensity Mapping
9.14. Drivers and Restraints Impact Analysis
9.15. Key Mergers & Acquisitions

10. China Botulinum Toxin Market Analysis 20132017 and Forecast 20182026
10.1. Introduction
10.2. Key Regulations
10.3. Historical Market Size (US$ Mn) Trend Analysis By Type of Toxin, 20132017
10.3.1. Type A
10.3.2. Type B
10.4. Market Size (US$ Mn) Forecast By Product Type, 20182026
10.5. Historical Market Size (US$ Mn) Trend Analysis By Application, 20132017
10.5.1. Cosmetic Application
10.5.1.1. Frown Lines/Galbellar
10.5.1.2. Crows Feet
10.5.1.3. Forehead Lines
10.5.1.4. Square Jaw Masseter
10.5.1.5. Others
10.5.2. Therapeutic Application
10.5.2.1. Chronic Migraine
10.5.2.2. Muscle Spasms
10.5.2.3. Over Reactive Bladder
10.5.2.4. Hyperhidrosis
10.5.2.5. Others
10.6. Market Size (US$ Mn) Forecast By Application, 20182026
10.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 20132017
10.7.1. Hospitals
10.7.2. Specialty Clinics
10.7.3. Spas & Beauty Clinics
10.8. Market Size (US$ Mn) Forecast By End User, 20182026
10.9. Drivers and Restraints: Impact Analysis
10.10. Market Attractiveness Analysis
10.10.1. By Country
10.10.2. By Type of Toxin
10.10.3. By Application
10.10.4. By End User
10.11. Key Market Participants Intensity Mapping
10.12. Drivers and Restraints Impact Analysis
10.13. Key Mergers & Acquisitions

11. Middle East & Africa Botulinum Toxin Market Analysis 20132017 and Forecast 20182026
Market forecast and analysis in GCC Countries, South Africa, and rest of MEA

11.1. Introduction
11.2. Key Regulations
11.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 20132017
11.3.1. GCC Countries
11.3.2. South Africa
11.3.3. Rest of MEA
11.4. Market Size (US$ Mn) Forecast By Country, 20182026
11.5. Historical Market Size (US$ Mn) Trend Analysis By Type of Toxin, 20132017
11.5.1. Type A
11.5.2. Type B
11.6. Market Size (US$ Mn) Forecast By Type of Toxin, 20182026
11.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 20132017
11.7.1. Cosmetic Application
11.7.1.1. Frown Lines/Galbellar
11.7.1.2. Crows Feet
11.7.1.3. Forehead Lines
11.7.1.4. Square Jaw Masseter
11.7.1.5. Others
11.7.2. Therapeutic Application
11.7.2.1. Chronic Migraine
11.7.2.2. Muscle Spasms
11.7.2.3. Over Reactive Bladder
11.7.2.4. Hyperhidrosis
11.7.2.5. Others
11.8. Market Size (US$ Mn) Forecast By Application, 20182026
11.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 20132017
11.9.1. Hospitals
11.9.2. Specialty Clinics
11.9.3. Spas & Beauty Clinics
11.10. Market Size (US$ Mn) Forecast By End User, 20182026
11.11. Drivers and Restraints: Impact Analysis
11.12. Market Attractiveness Analysis
11.12.1. By Country
11.12.2. By Type of Toxin
11.12.3. By Application
11.12.4. By End User
11.13. Key Market Participants Intensity Mapping
11.14. Drivers and Restraints Impact Analysis
11.15. Key Mergers & Acquisitions

12. Forecast Factors: Relevance and Impact

13. Forecast Assumptions

14. Market Structure Analysis

14.1. Market Structure by Tier of Companies
14.2. Market Share Analysis (2017) for Top 10 Players, By Region
14.3. Pricing Analysis By Key Players, By Region
14.4. Profitability and Gross Margin Analysis By Competition

15. Competition Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Company Deep Dive
15.3.1. Allergan Plc
15.3.1.1. Overview
15.3.1.2. Product and Application Portfolio
15.3.1.3. Production Footprint
15.3.1.4. Sales Footprint
15.3.1.5. Channel Footprint
15.3.1.6. Strategy
15.3.1.6.1.1. Marketing Strategy
15.3.1.6.1.2. Product Strategy
15.3.1.6.1.3. Channel Strategy
15.3.2. Daewoong Pharmaceuticals Co.Ltd.
15.3.2.1. Overview
15.3.2.2. Product and Application Portfolio
15.3.2.3. Production Footprint
15.3.2.4. Sales Footprint
15.3.2.5. Channel Footprint
15.3.2.6. Strategy
15.3.2.6.1.1. Marketing Strategy
15.3.2.6.1.2. Product Strategy
15.3.2.6.1.3. Channel Strategy
15.3.3. HUGEL Pharma
15.3.3.1. Overview
15.3.3.2. Product and Application Portfolio
15.3.3.3. Production Footprint
15.3.3.4. Sales Footprint
15.3.3.5. Channel Footprint
15.3.3.6. Strategy
15.3.3.6.1.1. Marketing Strategy
15.3.3.6.1.2. Product Strategy
15.3.3.6.1.3. Channel Strategy
15.3.4. Ipsen Group
15.3.4.1. Overview
15.3.4.2. Product and Application Portfolio
15.3.4.3. Production Footprint
15.3.4.4. Sales Footprint
15.3.4.5. Channel Footprint
15.3.4.6. Strategy
15.3.4.6.1.1. Marketing Strategy
15.3.4.6.1.2. Product Strategy
15.3.4.6.1.3. Channel Strategy
15.3.5. Medy-Tox Inc
15.3.5.1. Overview
15.3.5.2. Product and Application Portfolio
15.3.5.3. Production Footprint
15.3.5.4. Sales Footprint
15.3.5.5. Channel Footprint
15.3.5.6. Strategy
15.3.5.6.1.1. Marketing Strategy
15.3.5.6.1.2. Product Strategy
15.3.5.6.1.3. Channel Strategy
15.3.6. Merz Pharma GmbH & Co. KGaA
15.3.6.1. Overview
15.3.6.2. Product and Application Portfolio
15.3.6.3. Production Footprint
15.3.6.4. Sales Footprint
15.3.6.5. Channel Footprint
15.3.6.6. Strategy
15.3.6.6.1.1. Marketing Strategy
15.3.6.6.1.2. Product Strategy
15.3.6.6.1.3. Channel Strategy
15.3.6.6.1.4.
15.3.7. U.S. WorldMeds
15.3.7.1. Overview
15.3.7.2. Product and Application Portfolio
15.3.7.3. Production Footprint
15.3.7.4. Sales Footprint
15.3.7.5. Channel Footprint
15.3.7.6. Strategy
15.3.7.6.1.1. Marketing Strategy
15.3.7.6.1.2. Product Strategy
15.3.7.6.1.3. Channel Strategy
15.3.8. Hugh Source (International) Ltd.
15.3.8.1. Overview
15.3.8.2. Product and Application Portfolio
15.3.8.3. Production Footprint
15.3.8.4. Sales Footprint
15.3.8.5. Channel Footprint
15.3.8.6. Strategy
15.3.8.6.1.1. Marketing Strategy
15.3.8.6.1.2. Product Strategy
15.3.8.6.1.3. Channel Strategy

16. Global Botulinum Toxin Market Analysis 20132017 and Forecast 20182026, By Region
16.1. Introduction/Key Findings
16.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 20132017
16.3. Market Size (US$ Mn) Forecast By Region, 20182026
16.3.1. North America
16.3.2. Latin America
16.3.3. Europe
16.3.4. Asia Pacific
16.3.5. Middle East & Africa
16.3.6. China
16.4. Market Attractiveness Analysis By Region

17. Global Botulinum Toxin Analysis 20132017 and Forecast 20182026, By Type of Toxin
17.1. Introduction/Key Findings
17.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 20132017
17.2.1. Type A
17.2.2. Type B
17.3. Market Size (US$ Mn) Forecast By Type of Toxin, 20182026
17.4. Market Attractiveness Analysis By Product Type

18. Global Botulinum Toxin Market Analysis 20132017 and Forecast 20182026, By Application
18.1. Introduction/Key Findings
18.2. Historical Market Size (US$ Mn) Trend Analysis By Application, 20132017
18.2.1. Cosmetic Application
18.2.1.1. Frown Lines/Galbellar
18.2.1.2. Crows Feet
18.2.1.3. Forehead Lines
18.2.1.4. Square Jaw Masseter
18.2.1.5. Others
18.2.2. Therapeutic Application
18.2.2.1. Chronic Migraine
18.2.2.2. Muscle Spasms
18.2.2.3. Over Reactive Bladder
18.2.2.4. Hyperhidrosis
18.3. Others Market Size (US$ Mn) Forecast By Application, 20182026
18.4. Market Attractiveness Analysis By Application

19. Global Botulinum Toxin Market Analysis 20132017 and Forecast 20182026, By End User
19.1. Introduction/Key Findings
19.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 20132017
19.2.1. Hospitals
19.2.2. Specialty Clinics
19.2.3. Spas & Beauty Clinics
19.3. Market Size (US$ Mn) Forecast By End User, 20182026
19.4. Market Attractiveness Analysis By End User

20. Global Botulinum Toxin Market Analysis 20132017 and Forecast 20182026
20.1. Market Value Share Analysis By All Segment
20.2. Y-o-Y Growth Analysis By All Segment
20.3. Absolute $ Opportunity

21. Assumptions & Acronyms

22. Research Methodology

List of Table

Table 1: Botulinum Toxin Types and its Target Sites
Table 2: List of Botulinum Toxin Products Approved
Table 3: North America Botulinum Toxin Market Size Analysis (US$ Mn) Analysis 2013-2016 and Forecast 2017-2026, By Country
Table 4: North America Botulinum Toxin Market Size Analysis (US$ Mn) Analysis 2013-2016 and Forecast 2017-2026, By Product Type
Table 5: North America Botulinum Toxin Fraction Market Size Analysis (US$ Mn) Analysis 2013-2016 and Forecast 2017-2026, By Application
Table 6: North America Botulinum Toxin Fraction Market Size Analysis (US$ Mn) Analysis 2013-2016 and Forecast 2017-2026, By End-User
Table 7: Latin America Botulinum Toxin Market Size Analysis (US$ Mn) Analysis 2013-2016 and Forecast 2017-2026, By Country
Table 8: Latin America Botulinum Toxin Market Size Analysis (US$ Mn) Analysis 2013-2016 and Forecast 2017-2026, By Product Type
Table 9: Latin America Botulinum Toxin Fraction Market Size Analysis (US$ Mn) Analysis 2013-2016 and Forecast 2017-2026, By Application
Table 10: Latin America Botulinum Toxin Fraction Market Size Analysis (US$ Mn) Analysis 2013-2016 and Forecast 2017-2026, By End-User
Table 11: Europe Botulinum Toxin Market Size Analysis (US$ Mn) Analysis 2013-2016 and Forecast 2017-2026, By Country
Table 12: Europe Botulinum Toxin Market Size Analysis (US$ Mn) Analysis 2013-2016 and Forecast 2017-2026, By Product Type
Table 13: Europe Botulinum Toxin Fraction Market Size Analysis (US$ Mn) Analysis 2013-2016 and Forecast 2017-2026, By Application
Table 14: Europe Botulinum Toxin Fraction Market Size Analysis (US$ Mn) Analysis 2013-2016 and Forecast 2017-2026, By End-User
Table 15: Asia-Pacific Botulinum Toxin Market Size Analysis (US$ Mn) Analysis 2013-2016 and Forecast 2017-2026, By Country
Table 16: Asia-Pacific Botulinum Toxin Market Size Analysis (US$ Mn) Analysis 2013-2016 and Forecast 2017-2026, By Product Type
Table 17: Asia-Pacific Botulinum Toxin Fraction Market Size Analysis (US$ Mn) Analysis 2013-2016 and Forecast 2017-2026, By Application
Table 18: Asia-Pacific Botulinum Toxin Fraction Market Size Analysis (US$ Mn) Analysis 2013-2016 and Forecast 2017-2026, By End-User
Table 19: China Botulinum Toxin Market Size Analysis (US$ Mn) Analysis 2013-2016 and Forecast 2017-2026, By Product Type
Table 20: China Botulinum Toxin Fraction Market Size Analysis (US$ Mn) Analysis 2013-2016 and Forecast 2017-2026, By Application
Table 21: China Botulinum Toxin Fraction Market Size Analysis (US$ Mn) Analysis 2013-2016 and Forecast 2017-2026, By End-User
Table 22: Middle East & Africa Botulinum Toxin Market Size Analysis (US$ Mn) Analysis 2013-2016 and Forecast 2017-2026, By Country
Table 23: Middle East & Africa Botulinum Toxin Market Size Analysis (US$ Mn) Analysis 2013-2016 and Forecast 2017-2026, By Product Type
Table 24: Middle East & Africa Botulinum Toxin Market Size Analysis (US$ Mn) Analysis 2013-2016 and Forecast 2017-2026, By Application
Table 25: Middle East & Africa Botulinum Toxin Fraction Market Size Analysis (US$ Mn) Analysis 2013-2016 and Forecast 2017-2026, By End-User
Table 26: Global Botulinum Toxin Market size (US$ Mn) Analysis 20132016 and Forecast 20172026, By Region
Table 27: Global Botulinum Toxin Market size (US$ Mn) Analysis 20132016 and Forecast 20172026, By Product Type
Table 28: Global Botulinum Toxin Market Size Analysis (US$ Mn) Analysis 2013-2016 and Forecast 2017-2026, By Application
Table 29: Global Botulinum Toxin Market size (US$ Mn) Analysis 20132016 and Forecast 20172026, By End User
 

List of Chart

Figure 1: Company Share and Key Players in the Botulinum Toxin Market (2018 E)
Figure 2: Global Botulinum Toxin Market Share by Region (2018 E)
Figure 3: Global Botulinum Toxin Market Share by End Users (2018 E)
Figure 4: Wheel Of Fortune
Figure 5: Number of Aesthetic Procedures, 2015 & 2016
Figure 6: Number of Non-Surgical Aesthetic Procedures, 2015 & 2016
Figure 7: Number of Botulinum Toxin Procedures, 2016
Figure 8: North America Botulinum Toxin Market Value Share, By Country (2018)
Figure 9: North America Botulinum Toxin Market Value Share, By Product Type (2018)
Figure 10: North America Botulinum Toxin Market Value Share, By Applications (2018)
Figure 11: North America Botulinum Toxin Market Value Share, By End-Users (2018)
Figure 12: North America Botulinum Toxin Market Size (US$ Mn) Analysis, 2013-2017
Figure 13: North America Botulinum Toxin Market Size (US$ Mn) & Y-o-Y Growth (%), 20172026
Figure 14: U.S. Botulinum Toxin Market Size (US$ Mn) Analysis, 20132017
Figure 15: U.S. Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), 20172026
Figure 16: Canada Botulinum Toxin Market Size (US$ Mn) Analysis, 20132017
Figure 17: Canada Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), 20172026
Figure 18: North America Botulinum Toxin Market Size (US$ Mn) Analysis, Type A, 20132017
Figure 19: North America Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Type A, 20172026
Figure 20: North America Botulinum Toxin Market Size (US$ Mn) Analysis, Type B, 20132017
Figure 21: North America Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Type B, 20172026
Figure 22: North America Botulinum Toxin Market Size (US$ Mn) Analysis, by Cosmetic Application, 20132017
Figure 23: North America Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), by Cosmetic Application 20172026
Figure 24: North America Botulinum Toxin Market Size (US$ Mn) Analysis, by Therapeutic Application, 20132017
Figure 25: North America Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), by Therapeutic Application, 20172026
Figure 26: North America Botulinum Toxin Market Size (US$ Mn) Analysis, Hospitals, 20132017
Figure 27: North America Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Hospitals, 20172026
Figure 28: North America Botulinum Toxin Market Size (US$ Mn) Analysis, Specialty Clinics, 20132017
Figure 29: North America Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Specialty Clinics, 20172026
Figure 30: North America Botulinum Toxin Market Size (US$ Mn) Analysis, Spas & Beauty Clinics, 20132017
Figure 31: North America Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Spas & Beauty Clinics, 20172026
Figure 32: North America Botulinum Market Attractiveness Analysis, By Country
Figure 33: North America Botulinum Toxin Market Attractiveness Analysis, By Product Type
Figure 34: North America Botulinum Toxin Market Attractiveness Analysis, By Application
Figure 35: North America Botulinum Toxin Market Attractiveness Analysis, By End-User
Figure 36: Latin America Botulinum Toxin Market Value Share, By Country (2018)
Figure 37: Latin America Botulinum Toxin Market Value Share, By Product Type (2018)
Figure 38: Latin America Botulinum Toxin Market Value Share, By Applications (2018)
Figure 39: Latin America Botulinum Toxin Market Value Share, By End-Users (2018)
Figure 40: Latin America Botulinum Toxin Market Size (US$ Mn) Analysis, 2013-2017
Figure 41: Latin America Botulinum Toxin Market Size (US$ Mn) & Y-o-Y Growth (%), 20172026
Figure 42: Brazil Botulinum Toxin Market Size (US$ Mn) Analysis, 20132017
Figure 43: Brazil Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), 20172026
Figure 44: Mexico Botulinum Toxin Market Size (US$ Mn) Analysis, 20132017
Figure 45: Mexico Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), 20172026
Figure 46: Rest of Latin America Botulinum Toxin Market Size (US$ Mn) Analysis, 20132017
Figure 47: Rest of Lain America Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), 20172026
Figure 48: Latin America Botulinum Toxin Market Size (US$ Mn) Analysis, Type A, 20132017
Figure 49: Latin America Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Type A, 20172026
Figure 50: Latin America Botulinum Toxin Market Size (US$ Mn) Analysis, Type B, 20132017
Figure 51: Latin America Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Type B, 20172026
Figure 52: Latin America Botulinum Toxin Market Size (US$ Mn) Analysis, Cosmetic Application, 20132017
Figure 53: Latin America Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Cosmetic Application, 20172026
Figure 54: Latin America Botulinum Toxin Market Size (US$ Mn) Analysis, Therapeutic Application, 20132017
Figure 55: Latin America Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Therapeutic Application, 20172026
Figure 56: Latin America Botulinum Toxin Market Size (US$ Mn) Analysis, Hospitals, 20132017
Figure 57: Latin America Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Hospitals, 20172026
Figure 58: Latin America Botulinum Toxin Market Size (US$ Mn) Analysis, Specialty Clinics, 20132017
Figure 59: Latin America Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Specialty Clinics, 20172026
Figure 60: Latin America Botulinum Toxin Market Size (US$ Mn) Analysis, Spas & Beauty Clinics, 20132017
Figure 61: Latin America Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Spas & Beauty Clinics, 20172026
Figure 62: Latin America Botulinum Market Attractiveness Analysis, By Country
Figure 63: Latin America Botulinum Toxin Market Attractiveness Analysis, By Product Type
Figure 64: Latin America Botulinum Toxin Market Attractiveness Analysis, By Application
Figure 65: Latin America Botulinum Toxin Market Attractiveness Analysis, By End-User
Figure 66: Europe Botulinum Toxin Market Value Share, By Country (2018)
Figure 67: Europe Botulinum Toxin Market Value Share, By Product Type (2018)
Figure 68: Europe Botulinum Toxin Market Value Share, By Applications (2018)
Figure 69: Europe Botulinum Toxin Market Value Share, By End-Users (2018)
Figure 70: Europe Botulinum Toxin Market Size (US$ Mn) Analysis, 2013-2017
Figure 71: Europe Botulinum Toxin Market Size (US$ Mn) & Y-o-Y Growth (%), 20172026
Figure 72: Italy Botulinum Toxin Market Size (US$ Mn) Analysis, 20132017
Figure 73: Italy Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), 20172026
Figure 74: Spain Botulinum Toxin Market Size (US$ Mn) Analysis, 20132017
Figure 75: Spain Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), 20172026
Figure 76: Germany Botulinum Toxin Market Size (US$ Mn) Analysis, 20132017
Figure 77: Germany Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), 20172026
Figure 78: Russia Botulinum Toxin Market Size (US$ Mn) Analysis, 20132017
Figure 79: Russia Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), 20172026
Figure 80: U.K. Botulinum Toxin Market Size (US$ Mn) Analysis, 20132017
Figure 81: U.K. Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), 20172026
Figure 82: France Botulinum Toxin Market Size (US$ Mn) Analysis, 20132017
Figure 83: France Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), 20172026
Figure 84: Rest of Europe Botulinum Toxin Market Size (US$ Mn) Analysis, 20132017
Figure 85: Rest of Europe Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), 20172026
Figure 86: Europe Botulinum Toxin Market Size (US$ Mn) Analysis, Type A, 20132017
Figure 87: Europe Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Type A, 20172026
Figure 88: Europe Botulinum Toxin Market Size (US$ Mn) Analysis, Type B, 20132017
Figure 89: Europe Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Type B, 20172026
Figure 90: Europe Botulinum Toxin Market Size (US$ Mn) Analysis, Cosmetic Application, 20132017
Figure 91: Europe Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Cosmetic Application, 20172026
Figure 92: Europe Botulinum Toxin Market Size (US$ Mn) Analysis, Therapeutic Application, 20132017
Figure 93: Europe Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Therapeutic Application, 20172026
Figure 94: Europe Botulinum Toxin Market Size (US$ Mn) Analysis, Hospitals, 20132017
Figure 95: Europe Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Hospitals, 20172026
Figure 96: Europe Botulinum Toxin Market Size (US$ Mn) Analysis, Specialty Clinics, 20132017
Figure 97: Europe Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Specialty Clinics, 20172026
Figure 98: Europe Botulinum Toxin Market Size (US$ Mn) Analysis, Spas & Beauty Clinics, 20132017
Figure 99: Europe Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Spas & Beauty Clinics, 20172026
Figure 100: Europe Botulinum Market Attractiveness Analysis, By Country
Figure 101: Europe Botulinum Toxin Market Attractiveness Analysis, By Product Type
Figure 102: Europe Botulinum Toxin Market Attractiveness Analysis, By Application
Figure 103: Europe Botulinum Toxin Market Attractiveness Analysis, By End-User
Figure 104: Asia-Pacific Botulinum Toxin Market Value Share, By Country (2018)
Figure 105: Asia-Pacific Botulinum Toxin Market Value Share, By Product Type (2018)
Figure 106: Asia-Pacific Botulinum Toxin Market Value Share, By Applications (2018)
Figure 107: Asia-Pacific Botulinum Toxin Market Value Share, By End-Users (2018)
Figure 108: Asia-Pacific Botulinum Toxin Market Size (US$ Mn) Analysis, 2013-2017
Figure 109: Asia-Pacific Botulinum Toxin Market Size (US$ Mn) & Y-o-Y Growth (%), 20172026
Figure 110: India Botulinum Toxin Market Size (US$ Mn) Analysis, 20132017
Figure 111: India Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), 20172026
Figure 112: Japan Botulinum Toxin Market Size (US$ Mn) Analysis, 20132017
Figure 113: Japan Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), 20172026
Figure 114: Australia Botulinum Toxin Market Size (US$ Mn) Analysis, 20132017
Figure 115: Australia Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), 20172026
Figure 116: Rest of Asia-Pacific Botulinum Toxin Market Size (US$ Mn) Analysis, 20132017
Figure 117: Rest of Asia-Pacific Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), 20172026
Figure 118: Asia-Pacific Botulinum Toxin Market Size (US$ Mn) Analysis, Type A, 20132017
Figure 119: Asia-Pacific Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Type A, 20172026
Figure 120: Asia-Pacific Botulinum Toxin Market Size (US$ Mn) Analysis, Type B, 20132017
Figure 121: Asia-Pacific Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Type B, 20172026
Figure 122: Asia-Pacific Botulinum Toxin Market Size (US$ Mn) Analysis, Cosmetic Application, 20132017
Figure 123: Asia-Pacific Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Cosmetic Application, 20172026
Figure 124: Asia-Pacific Botulinum Toxin Market Size (US$ Mn) Analysis, Therapeutic Application, 20132017
Figure 125: Asia-Pacific Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Therapeutic Application, 20172026
Figure 126: Asia-Pacific Botulinum Toxin Market Size (US$ Mn) Analysis, Hospitals, 20132017
Figure 127: Asia-Pacific Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Hospitals, 20172026
Figure 128: Asia-Pacific Botulinum Toxin Market Size (US$ Mn) Analysis, Specialty Clinics, 20132017
Figure 129: Asia-Pacific Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Specialty Clinics, 20172026
Figure 130: Asia-Pacific Botulinum Toxin Market Size (US$ Mn) Analysis, Spas & Beauty Clinics, 20132017
Figure 131: Asia-Pacific Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Spas & Beauty Clinics, 20172026
Figure 132: Asia-Pacific Botulinum Market Attractiveness Analysis, By Country
Figure 133: Asia-Pacific Botulinum Toxin Market Attractiveness Analysis, By Product Type
Figure 134: Asia-Pacific Botulinum Toxin Market Attractiveness Analysis, By Application
Figure 135: Asia-Pacific Botulinum Toxin Market Attractiveness Analysis, By End-User
Figure 136: China Botulinum Toxin Market Value Share, By Product Type (2018)
Figure 137: China Botulinum Toxin Market Value Share, By Applications (2018)
Figure 138: China Botulinum Toxin Market Value Share, By End-Users (2018)
Figure 139: China Botulinum Toxin Market Size (US$ Mn) Analysis, 2013-2016
Figure 140: China Botulinum Toxin Market Size (US$ Mn) & Y-o-Y Growth (%), 20172026
Figure 141: China Botulinum Toxin Market Size (US$ Mn) Analysis, Type A, 20132017
Figure 142: China Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Type A, 20172026
Figure 143: China Botulinum Toxin Market Size (US$ Mn) Analysis, Cosmetic Application, 20132017
Figure 144: China Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Cosmetic Application, 20172026
Figure 145: China Botulinum Toxin Market Size (US$ Mn) Analysis, Therapeutic Application, 20132017
Figure 146: China Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Therapeutic Application, 20172026
Figure 147: China Botulinum Toxin Market Size (US$ Mn) Analysis, Hospitals, 20132017
Figure 148: China Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Hospitals, 20172026
Figure 149: China Botulinum Toxin Market Size (US$ Mn) Analysis, Specialty Clinics, 20132017
Figure 150: China Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Specialty Clinics, 20172026
Figure 151: China Botulinum Toxin Market Size (US$ Mn) Analysis, Spas & Beauty Clinics, 20132017
Figure 152: China Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Spas & Beauty Clinics, 20172026
Figure 153: China Botulinum Toxin Market Attractiveness Analysis, By Type
Figure 154: China Botulinum Toxin Market Attractiveness Analysis, By End-User
Figure 155: China Botulinum Toxin Market Attractiveness Analysis, By Product Type
Figure 156: Middle East & Africa Botulinum Toxin Market Value Share, By Country (2018)
Figure 157: Middle East & Africa Botulinum Toxin Market Value Share, By Product Type (2018)
Figure 158: Middle East & Africa Botulinum Toxin Market Value Share, By Applications (2018)
Figure 159: Middle East & Africa Botulinum Toxin Market Value Share, By End-Users (2018)
Figure 160: Middle East & Africa Botulinum Toxin Market Size (US$ Mn) Analysis, 2013-2016
Figure 161: Middle East & Africa Botulinum Toxin Market Size (US$ Mn) & Y-o-Y Growth (%), 20172026
Figure 162: Turkey Botulinum Toxin Market Size (US$ Mn) Analysis, 20132016
Figure 163: Turkey Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), 20172026
Figure 164: Egypt Botulinum Toxin Market Size (US$ Mn) Analysis, 20132016
Figure 165: Egypt Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), 20172026
Figure 166: Rest of Middle East & Africa Botulinum Toxin Market Size (US$ Mn) Analysis, 20132016
Figure 167: Rest of Middle East & Africa Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), 20172026
Figure 168: Middle East & Africa Botulinum Toxin Market Size (US$ Mn) Analysis, Type A, 20132017
Figure 169: Middle East & Africa Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Type A, 20172026
Figure 170: Middle East & Africa Botulinum Toxin Market Size (US$ Mn) Analysis, Cosmetic Application, 20132017
Figure 171: Middle East & Africa Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Cosmetic Application, 20172026
Figure 172: Middle East & Africa Botulinum Toxin Market Size (US$ Mn) Analysis, Therapeutic Application, 20132017
Figure 173: Middle East & Africa Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Therapeutic Application, 20172026
Figure 174: Middle East & Africa Botulinum Toxin Market Size (US$ Mn) Analysis, Hospitals, 20132017
Figure 175: Middle East & Africa Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Hospitals, 20172026
Figure 176: Middle East & Africa Botulinum Toxin Market Size (US$ Mn) Analysis, Specialty Clinics, 20132017
Figure 177: Middle East & Africa Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Specialty Clinics, 20172026
Figure 178: Middle East & Africa Botulinum Toxin Market Size (US$ Mn) Analysis, Spas & Beauty Clinics, 20132017
Figure 179: Middle East & Africa Botulinum Toxin Market Value (US$ Mn) & Y-o-Y Growth (%), Spas & Beauty Clinics, 20172026
Figure 180: Middle East & Africa Botulinum Market Attractiveness Analysis, By Country
Figure 181: Middle East & Africa Botulinum Toxin Market Attractiveness Analysis, By Product Type
Figure 182: Middle East & Africa Botulinum Toxin Market Attractiveness Analysis, By Application
Figure 183: Middle East & Africa Botulinum Toxin Market Attractiveness Analysis, By End-User
Figure 184: Global Botulinum Toxin Market Share Analysis (%) By Region, 2018 & 2026
Figure 185: Global Botulinum Toxin Market Y-o-Y Growth (%) By Region, 20182026
Figure 186: Global Botulinum Toxin Market Attractiveness Analysis By Region, 20182026
Figure 187: Global Botulinum Toxin Market Share Analysis (%) By Product Type, 2018 & 2026
Figure 188: Global Botulinum Toxin Market Y-o-Y Growth (%) By Product Type, 20182026
Figure 189: Global Botulinum Toxin Market Attractiveness Analysis By Product Type, 20182026
Figure 190: Global Botulinum Toxin Market Y-o-Y Growth (%) By Application, 20182026
Figure 191: Global Botulinum Toxin Market Share Analysis (%) By Application, 2018 & 2026
Figure 192: Global Botulinum Toxin Market Share Analysis (%) By Therapeutic Application, 2018 & 2026
Figure 193: Global Botulinum Toxin Market Share Analysis (%) By Cosmetic Application, 2018 & 2026
Figure 194: Global Botulinum Toxin Market Attractiveness Analysis By Application, 20182026
Figure 195: Global Botulinum Toxin Market Attractiveness Analysis By Therapeutic Application, 20182026
Figure 196: Global Botulinum Toxin Market Attractiveness Analysis By Cosmetic Application, 20182026
Figure 197: Global Botulinum Toxin Market Share Analysis (%) By End User, 2018 & 2026
Figure 198: Global Botulinum Toxin Market Y-o-Y Growth (%) By End User, 20182026
Figure 199: Global Botulinum Toxin Market Attractiveness Analysis By End User, 20182026
Figure 200: Global Botulinum Toxin Market Value Analysis and Forecast, 20162025 (US$ Mn)
Figure 201: Global Botulinum Toxin Market Value (US$ Mn), 20132017
Figure 202: Global botulinum Toxin Market Absolute $ Opportunity (US$ Mn), 20172026

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *